| Seer, Inc.. (12/17/19). "Press Release: Seer Announces $55 Million in Series D Equity Financing. Bringing in New Investors aMoon Fund and T. Rowe Price Funds". Redwood City, CA. |
2019-12-17 |
| Resistell AG. (12/17/19). "Press Release: Resistell AG Closes CHF 3.5M Series A Financing Round". |
2019-12-17 |
| Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. |
2019-12-17 |
| Sixfold Bioscience Ltd.. (12/17/19). "Press Release: Sixfold Bioscience Awarded Two Innovate UK Grants". |
2019-12-17 |
| Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe |
2019-12-16 |
| Sphingotec GmbH. (12/16/19). "Press Release: Sphingotec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. |
2019-12-16 |
| Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". |
2019-12-16 |
| Federal Trade Commission. (12/16/19). "Press Release: Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.". |
2019-12-16 |
| Flagship Pioneering. (12/16/19). "Press Release: Flagship Pioneering Strengthens Leadership with Appointment of Paul Biondi as Executive Partner". Cambridge, MA. |
2019-12-16 |
| Augustine Therapeutics. (12/16/19). "Press Release: VIB and KU Leuven Announce New Spin-off Augustine Therapeutics to Fight Neuromuscular Diseases". Belgium. |
2019-12-16 |
| GlaxoSmithKline plc. (12/16/19). "Press Release: Pivotal DREAMM-2 Study Demonstrated a Clinically Meaningful Overall Response Rate with Belantamab Mafodotin (GSK2857916) for Patients with relapsed/refractory Multiple Myeloma". London. |
2019-12-16 |
| Immunicum AB. (12/13/19). "Press Release: Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO". |
2019-12-13 |
| Boehringer Ingelheim. (12/13/19). "Press Release: Boehringer Ingelheim and Lilly Provide Update on Empagliflozin Phase III Exercise Ability Studies in Chronic Heart Failure". Ingelheim & Indianapolis, IN. |
2019-12-13 |
| Genmab A/S. (12/13/19). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma". Copenhagen. |
2019-12-13 |
| Aelis Farma. (12/13/19). "Press Release: Aelis Farma Raises €11 Million to Accelerate the Clinical Development of a Paradigm-Shifting New Class of Drugs for Treating Cannabis Addiction and Cognitive Disorders". Bordeaux. |
2019-12-13 |
| Innate Pharma S.A.. (12/13/19). "Press Release: Innate Pharma Provides Update on Lacutamab TELLOMAK Trial". Marseille. |
2019-12-13 |
| Bioncotech Therapeutics S.L.. (12/12/19). "Press Release: Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019". Madrid. |
2019-12-12 |
| Numab Therapeutics AG. (12/12/19). "Press Release: Numab Therapeutics and 3SBio’s Subsidiary Sunshine Guojian Form Partnership to Develop a Portfolio of Novel Multi-specific Antibodies in Immuno-Oncology". Wädenswil, Shengyang & Shanghai. |
2019-12-12 |
| iTeos Therapeutics S.A.. (12/12/19). "Press Release: iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with Keytruda". Gosselies & Cambridge, MA. |
2019-12-12 |
| Start Codon Ltd.. (12/11/19). "Press Release: Start Codon and One Nucleus Partner to Support UK Life Science Ecosystem. Start Codon Cohort Companies to Receive One Nucleus Membership Benefits". Cambridge. |
2019-12-11 |
| Inscripta, Inc.. (12/10/19). "Press Release: Inscripta Raises $125m in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform". Boulder, CO. |
2019-12-10 |
| Charles River Laboratories International, Inc.. (12/10/19). "Press Release: Charles River Announces Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies". Wilmington, MA. |
2019-12-10 |
| TU Braunschweig. (12/10/19). "Pressemitteilung: Start-up zu nachhaltiger Antikörper-Produktion Ausgründung der TU Braunschweig arbeitet an breiter Anwendung". |
2019-12-10 |
| Markes International Ltd.. (12/10/19). "Press Release: Markes Becomes Licensed World Commercial Supplier of Thin-Film Solid-Phase Microextraction (TF-SPME)". |
2019-12-10 |
| Bioncotech Therapeutics S.L.. (12/10/19). "Press Release: Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD. Phase II Trial with Combination of BO-112 and Pembrolizumab". Madrid. |
2019-12-10 |
| Stilla Technologies S.A.S.. (12/10/19). "Press Release: Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution". Paris. |
2019-12-10 |
| ImmunOs Therapeutics AG. (12/10/19). "Press Release: ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer into Human Trials". Schlieren. |
2019-12-10 |
| Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. |
2019-12-10 |
| Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich). |
2019-12-10 |
| Algiax Pharmaceuticals. (12/9/19). "Press Release: Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors". Düsseldorf. |
2019-12-09 |
| Bruker Corporation. (12/9/19). "Press Release: Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging". Washington, DC. |
2019-12-09 |
| ObsEva S.A.. (12/9/19). "Press Release: ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix". Geneva & Boston, MA. |
2019-12-09 |
| Epidarex Capital. (12/9/19). "Press Release: Epidarex Exeed Founded by Epidarex Capital to Advance Early Stage, Highly Innovative Life Science Assets". Edinburgh. |
2019-12-09 |
| Sanofi S.A.. (12/9/19). "Press Release: Sanofi to Acquire Synthorx to Bolster Its Immuno-oncology Pipeline for $2.5 Billion". Paris & San Diego, CA. |
2019-12-09 |
| BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. |
2019-12-06 |
| Jasper Therapeutics, Inc.. (12/6/19). "Press Release: Jasper Therapeutics Launches with $35 Million Series A Financing to Develop and Commercialize Innovative Conditioning Agents and Therapies to Transform Curative Hematopoietic Cell Transplants". Palo A |
2019-12-06 |
| Scope Fluidics S.A.. (12/6/19). "Press Release: Scope Fluidics Has Launched a Manufacturing Line for PCR System Chips". Warsaw. |
2019-12-06 |
| Deinove S.A.. (12/6/19). "Press Release: Evolution in Deinove’s Governance. Emmanuel Petiot Will Resign as Chief Executive Officer ("CEO") as of December 31, 2019". Montpellier. |
2019-12-06 |
| Eppendorf AG. (12/6/19). "Press Release: Eppendorf with New CEO Dual Leadership. Eva van Pelt and Dr. Peter Fruhstorfer Appointed Co-CEOs – Former CEO, Thomas Bachmann, Left the Company". Hamburg. |
2019-12-06 |
| 4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. |
2019-12-05 |
| Sartorius AG. (12/5/19). "Press Release: Sartorius Acquires a Majority Stake in Cell Culture Media Specialist Biological Industries". Göttingen. |
2019-12-05 |
| Sartorius AG. (12/5/19). "Press Release: Sartorius Supervisory Board Extends Appointment of Group CEO Joachim Kreuzburg". Göttingen. |
2019-12-05 |
| Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC. |
2019-12-05 |
| Unibio International plc. (12/4/19). "Press Release: Mitsubishi Corporation Invests in, and Partners with, Unibio". London & Copenhagen. |
2019-12-04 |
| ImCheck Therapeutics S.A.S.. (12/4/19). "Press Release: ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases". Marseille. |
2019-12-04 |
| Kuros Biosciences Ltd.. (12/3/19). "Press Release: Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of CHF 12.5 Million Raised [Not for US, UK, AU, et al.]". Schlieren. |
2019-12-03 |
| Mologen AG. (12/3/19). "Press Release: Insolvency Filing [Not for publication or distribution in or into US, AU, CA or JP or any jurisdiction in which unlawful]". Berlin. |
2019-12-03 |
| BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. |
2019-12-02 |
| Diabeloop S.A.. (12/2/19). "Press Release: Diabeloop Completes Record-breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions". Grenoble. |
2019-12-02 |
| CureVac AG. (12/2/19). "Press Release: CureVac Granted Manufacturing Authorization for Its Third GMP Production Suite". Tübingen & Boston, MA. |
2019-12-02 |
| Lunac Therapeutics Ltd.. (12/2/19). "Press Release: Lunac Therapeutics Led Project Awarded £3.14 Million under Innovate UK Biomedical Catalyst Programme, to Develop Next-generation Anticoagulant". Leeds. |
2019-12-02 |
| Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier. |
2019-12-02 |
| Ligand Pharmaceuticals Inc.. (12/2/19). "Press Release: Ligand Enters into Worldwide OmniAb Platform License Agreement with Sanofi". San Diego, CA. |
2019-12-02 |
| Indivumed GmbH. (12/2/19). "Press Release: Indivumed Announces Strategic Partnership with Biognosys". Hamburg & Schlieren. |
2019-12-02 |
| Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. |
2019-12-02 |
| Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/2/19). "Press Release: Deep Learning Identifies Molecular Patterns of Cancer". Berlin. |
2019-12-02 |
| Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York. |
2019-12-02 |
| Puma Biotechnology, Inc.. (12/2/19). "Press Release: Puma Biotechnology Amends License Agreement with Pierre Fabre to Include Additional Countries". Berlin. |
2019-12-02 |
| Audentes Therapeutics, Inc.. (12/2/19). "Press Release: Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics". Tokyo & San Francisco, CA. |
2019-12-02 |
| European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". |
2019-11-29 |
| ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. |
2019-11-28 |
| MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. |
2019-11-28 |
| Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. |
2019-11-28 |
| Markes International Ltd.. (11/28/19). "Press Release: New Appointment Signals Asia Pacific Market Growth for Markes International". |
2019-11-28 |
| Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. |
2019-11-27 |
| Helmholtz-Zentrum für Infektionsforschung (HZI. (11/27/19). "Press Release: Helmholtz Gets Three more Start-ups Off the Ground. HZI Spin-off Myxobiotics Researches Active Substance against Urinary Tract Infections". |
2019-11-27 |
| Lonza Group Ltd.. (11/26/19). "Press Release: Lonza and Dinaqor Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies". Basel & Pfäffikon. |
2019-11-26 |
| MaxiVax S.A.. (11/26/19). "Press Release: MaxiVax Awarded €2,785,000 European Commission Grant and Announces Successful Closing of Its Series B 2 Round for an Amount of CHF 5 Million". Geneva. |
2019-11-26 |
| Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. |
2019-11-26 |
| Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. |
2019-11-26 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (11/26/19). "Press Release: Establishing a New Standard for the Life Science Industry. SHS Supports Internationalization and Further Growth of Single Use Support". Tübingen & Kufstein. |
2019-11-26 |
| Alkermes plc. (11/25/19). "Press Release: Alkermes Completes Acquisition of Rodin Therapeutics". Dublin. |
2019-11-25 |
| Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA. |
2019-11-25 |
| Alexandria Real Estate Equities, Inc.. (11/25/19). "Press Release: Alexandria Real Estate Equities, Inc. Partners With World-Class Life Science Consortium in Greater Boston". Pasadena, CA. |
2019-11-25 |
| Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo. |
2019-11-25 |
| Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen. |
2019-11-25 |
| Roche. (11/25/19). "Press Release: FDA Grants Priority Review to Roche’s Risdiplam for Spinal Muscular Atrophy". Basel. |
2019-11-25 |
| BCNP Consultants GmbH. (11/25/19). "Press Release: World Café »Digitization of the Coating Industry« at the 4th European Chemistry Partnering on February 27, 2020". Frankfurt a. M.. |
2019-11-25 |
| GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. |
2019-11-25 |
| Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. |
2019-11-25 |
| ChemoCentryx Inc.. (11/25/19). "Press Release: ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis". Mountain View, CA & St. |
2019-11-25 |
| Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel. |
2019-11-24 |
| Roche. (11/22/19). "Press Release: Roche Presents Pivotal Data Demonstrating Tecentriq in Combination with Avastin Improves Overall Survival in People with the Most Common Form of Liver Cancer". Basel. |
2019-11-22 |
| Immunitas Therapeutics Inc.. (11/21/19). "Press Release: Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform". Boston, MA. |
2019-11-21 |
| Azeria Therapeutics Ltd.. (11/21/19). "Press Release: Azeria Therapeutics Announces £32.0 million Series B Financing". London. |
2019-11-21 |
| Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". |
2019-11-20 |
| Qiagen N.V.. (11/20/19). "Press Release: Qiagen and LabCorp Deepen Relationship with Widespread Use of Bioinformatics Solutions". Hilden & Germantown, MD. |
2019-11-20 |
| GHO Capital Partners LLP. (11/20/19). "Press Release: GHO Capital Raises €975m in Largest Ever European Healthcare Fund". London. |
2019-11-20 |
| CRISPR Therapeutics AG. (11/20/19). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-20 |
| Merck KGaA. (11/20/19). "Press Release: Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 8Not intended for UK-based media]". Darmstadt. |
2019-11-20 |
| Tissium. (11/20/19). "Press Release: Tissium Closes €39M Series B Funding Round". Paris. |
2019-11-20 |
| Sophia Genetics S.A.. (11/20/19). "Press Release: Sophia Genetics Welcomes Milton Silva-Craig to Its Board of Directors". Boston, MA & Lausanne. |
2019-11-20 |
| MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg. |
2019-11-20 |
| Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA. |
2019-11-19 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-19 |
| Novo Holdings A/S. (11/19/19). "Press Release: Novo Ventures and Broad Institute of MIT and Harvard Launch Drug Discovery »Greenhouse« to Drive Creation of Innovative New Therapies". Boston, MA. |
2019-11-19 |
| Causaly Ltd.. (11/19/19). "Press Release: Causaly Raises $5m in Series A Round Led by Pentech Ventures". London. |
2019-11-19 |
| Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. |
2019-11-19 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies". Zug |
2019-11-19 |
| Rentschler Biopharma SE. (11/18/19). "Press Release: Rentschler Biopharma Appoints New Executives to Join U.S. Team". Laupheim & Milford, MA. |
2019-11-18 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
1 2 3 ... 170 171 172 
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
